The following pages link to (Q3817442):
Displaying 31 items.
- Survival Analysis with Time-Varying Regression Effects Using a Tree-Based Approach (Q151457) (← links)
- Does Cox analysis of a randomized survival study yield a causal treatment effect? (Q269762) (← links)
- Least squares type estimation for Cox regression model and specification error (Q693234) (← links)
- Effects of unmeasured heterogeneity in the linear transformation model for censored data (Q849905) (← links)
- Relatives' risks: Frailty models of life history data (Q910149) (← links)
- On the ratio of hazard functions in the presence of a nuisance covariate (Q913433) (← links)
- Impact of covariate omission and categorization from the Fine-Gray model in randomized-controlled trials (Q2068947) (← links)
- Weighted Lindley frailty model: estimation and application to lung cancer data (Q2074079) (← links)
- Competing risk and the Cox proportional hazard model (Q2492499) (← links)
- Effect of covariate omission in Weibull accelerated failure time model: A caution (Q2931058) (← links)
- A Semiparametric Estimate of Treatment Effects with Censored Data (Q3078833) (← links)
- Erosion of Regression Effect in a Survival Study (Q3442962) (← links)
- Simpson's Paradox in Survival Models (Q3552965) (← links)
- (Q3707224) (← links)
- Effect of censoring on adjusting for covariates in comparison of survival times (Q3750886) (← links)
- Effects of omitting a covariate in poisson models when the data are balanced (Q4521150) (← links)
- EFFECT OF MISSING AN INFLUENTIAL COVARIATE (Q4540628) (← links)
- Unobserved confounder effects in models for clustered dental failure time data (Q4971012) (← links)
- Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored (Q5257926) (← links)
- Bias and Sensitivity Analysis When Estimating Treatment Effects from the Cox Model with Omitted Covariates (Q5408004) (← links)
- Econometric models of duration data in entrepreneurship with an application to start-ups' time-to-funding by venture capitalists (VCs) (Q5861211) (← links)
- Maximum Likelihood Estimation in the Additive Hazards Model (Q6055736) (← links)
- Effect of Covariate Omission in Randomised Controlled Trials: A Review and Simulation Study (Q6067161) (← links)
- Nonproportional hazards model with a frailty term for modeling subgroups with evidence of long‐term survivors: Application to a lung cancer dataset (Q6068327) (← links)
- A new cure rate frailty regression model based on a weighted Lindley distribution applied to stomach cancer data (Q6091278) (← links)
- Cox regression can be collapsible and aalen regression can be non-collapsible (Q6103253) (← links)
- Investigation of one-stage meta-analysis methods for joint longitudinal and time-to-event data through simulation and real data application (Q6625549) (← links)
- Two-stage residual inclusion for survival data and competing risks -- an instrumental variable approach with application to SEER-medicare linked data (Q6625586) (← links)
- Analysis of time-to-event for observational studies: guidance to the use of intensity models (Q6627876) (← links)
- Two-step hypothesis testing to detect gene-environment interactions in a genome-wide scan with a survival endpoint (Q6628047) (← links)
- Some approximations to the path formula for some nonlinear models (Q6641024) (← links)
